Related Experiment Video
Updated: Apr 6, 2026

09:51
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
Published on: May 18, 2018
11.3K
Toll-like receptor 2 activators modulate oral tolerance in mice
M C Tunis1,2, B Dawod2,3, K R Carson1,2
1Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.
Summary
Toll-like receptor 2 (TLR2) is not essential for oral tolerance but influences immune responses to food antigens. Activating TLR2 during food exposure can alter tolerance, impacting IgE and IgA antibody production, which is relevant for oral immunotherapy and vaccine development.
Area of Science:
- Immunology
- Allergy Research
- Mucosal Immunity
Background:
- Toll-like receptor 2 (TLR2) is a key innate immunity receptor involved in mucosal immunity and allergic disease development.
- The role of TLR2 in oral tolerance and allergic sensitization to food antigens remains unclear, despite TLR2 activators being present in common foods.
Purpose of the Study:
- To investigate the impact of TLR2 expression and activation on the development of oral tolerance to food antigens.
- To evaluate the role of TLR2 in modulating immune responses to food antigens in a murine model.
Main Methods:
- Mice were orally administered ovalbumin (OVA) or peanut butter, with or without TLR2 activators (Pam3 CSK4 or FSL-1).
- Oral tolerance was assessed by analyzing antibody responses post-systemic antigen challenge.
- Regulatory T-cell (Treg) populations were analyzed in wild-type and TLR2(-/-) mice.
- Low-dose Pam3 CSK4 was tested as an oral adjuvant.
Main Results:
- Oral tolerance was successfully induced in both wild-type and TLR2(-/-) mice, with Treg responses observed.
- Oral TLR2 activation during antigen exposure altered oral tolerance, leading to significant IgE and IgA responses upon systemic challenge.
- Low-dose oral Pam3 CSK4 enhanced antigen-specific IgA responses.
Conclusions:
- TLR2 is not required for inducing oral tolerance but modulates IgE and IgA humoral responses during this process.
- Low-dose Pam3 CSK4 acts as an effective oral adjuvant, specifically boosting IgA production.
- Findings are relevant for optimizing oral allergen immunotherapy and oral vaccine strategies.

